Drug induced Parkinson's disease. 1984

J Williamson

UI MeSH Term Description Entries
D010302 Parkinson Disease, Secondary Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42) Atherosclerotic Parkinsonism,Secondary Parkinsonism,Symptomatic Parkinson Disease,Parkinson Disease, Secondary Vascular,Parkinson Disease, Symptomatic,Parkinsonism, Secondary,Parkinsonism, Symptomatic,Secondary Vascular Parkinson Disease,Parkinsonism, Atherosclerotic,Secondary Parkinson Disease,Symptomatic Parkinsonism
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J Williamson
May 1987, Lancet (London, England),
J Williamson
February 1987, Lancet (London, England),
J Williamson
January 1995, Advances in neurology,
J Williamson
April 1990, Biochemical Society transactions,
J Williamson
April 1985, [Kango] Japanese journal of nursing,
J Williamson
September 2019, The Australian and New Zealand journal of psychiatry,
J Williamson
May 1983, Archives of neurology,
J Williamson
May 2011, Journal of neurology,
J Williamson
August 1999, The New England journal of medicine,
J Williamson
March 1999, Movement disorders : official journal of the Movement Disorder Society,
Copied contents to your clipboard!